Læknablaðið - 15.08.1996, Qupperneq 29

LÆKNABLAÐIÐ 1996; 82
575
son SW, Oyer PE, et al. Orthotopic heart and combined
heart-lung transplantation with cyclosporine A immuno-
suppression. Transplant Proc 1981: 13: 393-6.
6. Bailey LL, Nehlsen-Cannarella SL, Conception W, Jol-
ley WB. Baboon-to-human cardiac xenotransplantation
in a neonate. JAMA 1985; 254: 3321-9.
7. Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The
registry of the international society for heart and lung
transplantation: Eleventh official report-1994. J Heart
Lung Transplant 1994; 13: 561-70.
8. Fricker FJ, Armitage JM. Heart and heart-lung trans-
plantation in children and adolescents. In: Moss and
Adams heart disease in infants, children and adoles-
cents, 5th ed. Baltimore: Williams and Wilkins. 1989:
495-510.
9. Anguita M, Arizon JM, Valles F, Montero JA, Sancho
M. Bueno G, et al. Influenze on survival after heart
transplantation of contraindications seen in transplant
recipients. J Heart Lung Transplant 1992; 11: 708-15.
10. Menkis AH, McKenzie FN, Novick RJ, Kostuk WJ,
Pflugfelder PW, Goidback M, et al. Special consider-
ation for heart transplantation in congenital heart dis-
ease. J Heart Lung Transplant 1990; 9: 602-7.
11. Young JB, Leon CA, Short HD, Noon GP, Lawrence
EC, Whisennand HH, et al. Evolution of hemodynamics
after heart and heart-lung transplantation: Early restric-
tive pattems persisting in occult fashion. J Heart Trans-
plant 1987; 11: 5232-6.
12. Stark RP, McGinn AL, Wilson RF. Chest pain in car-
diac transplant recipients: Evidence of sensory reinnerv-
ation after cardiac transplantation. N Engl J Med 1991;
324: 1791-4.
13. Sigfússon G, PophalSG, WebberSA, NechesWH, Park
SC. Complication of Endomyocardial Biopsy in Chil-
dren. Abstract 24, p39. ln Programs and Abstracts of
Fourth Annual Fellow’s Research Day, American Heart
Association, March 1996. Pennsylvania Chapter Pitts-
burgh PA.
14. Myers BD, Sibley R, Newton L, Tomlanovich SJ, Bosh-
kos C, Stinson E, et al. The long-term course of cy-
closporine-associated chronic nephropathy. Kidney In-
ternational 1988; 33: 590-600.
15. Asante-Korang A, Boyle GJ, Webber SA, Miller SA,
Fricker FJ. Experience of FK506 immunosuppression in
pediatric heart transplantation: A study of long-term
adverse effects. J Heart Lung Transplant 1996 (in press).
16. Klintmalm GB. The US multicenter FK505 liver study
group. A comparison of Tacrolimus (FK506) and cy-
closporine for immunosuppression in liver transplanta-
tion. N Engl J Med 1994; 331: 1110-5.
17. Wagner K, Webber SA, Boyle GJ, Miller SA, Kurland
G, Griffith BP, et al. Association of Tacrolimus (FK
506) and diabetes mellitus in pediatric heart and heart-
lung transplant recipients. J Heart Lung Transplant
1996; 15: 81.
18. Addonizio L. Late complications of pediatric cardiac
transplantation. ACC Current Journal Review 1994; 3:
23-5.
19. MaddenB. Late complications aftercardiac transplanta-
tion. Br Heart J 1994; 72: 89-91.
20. Bernstein D, Baum D, Berry G, Dahl G, Weiss L,
Starnes VA, et al. Neoplastic disorders after pediatric
heart transplantation. Circulation 1993; 88: II 230-7.
21. Billingham ME. Diagnosis of cardiac rejection by endo-
myocardial biopsy. Heart Transplant 1982; 1: 25-30.
22. Billingham ME, Cary NRB, Hammond ME, Kemnitz J,
Marboe C, McCalliester HA, et al. A working formula-
tion for the standardization of nomenclature in the diag-
nosis of heart and lung rejection: Heart rejection study
group. J Heart Lung Transplant 1990; 9: 587-93.
23. Pahl E, Fricker FJ, Armitage J, Griffith BP, Taylor S,
Uretsky BF, et al. Coronary arteriosclerosis in pediatric
heart transplant survivors: Limitations of long-term sur-
vival. J Pediatr 1990; 116: 177-83.
24. Uretsky BF, Kormos RL, Zerbe TR, Lee A, Tokarczyk
TR, Murali S, et al. Cardiac events after heart trans-
plantation: Incidence and predictive value of coronary
angiography. J Heart and Lung Transplant 1992; 11:
45-51.
25. St.Goar FG, Pinto FJ, Alderman EL, Valantine HA,
Schroeder JS, Gao SZ, et al. Intracoronary ultrasound
in cardiac transplant recipients: In vivo evidence of „an-
giographically'' silent intimal thickening. Circulation
1992; 85: 979-87.
26. Pahl E, Zales VR, Fricker FJ, Addonizio LJ. Post-
transplant coronary artery disease in children: A multi-
center national survey. Circulation 1994; 90: II 56-60.
27. Addonizio LJ, Hsu DT, Douglas JF, Kichuk MR, Mi-
chler RE, Quaegebeur JM, et al. Decreasing incidence
of coronary disease in pediatric cardiac transplant recip-
ients using increased immunosuppression. Circulation
1993; 88: II 224-9.
28. Sigfússon G, Boyle GJ, Miller SA, Webber SA, Mi-
chaels MG, Kurland G, et al. Acute and Chronic Heart
Allograft Rejection in Heart — Lung transplant Reci-
pents. Pediatric Cardiology 1995; 16 260 Abstract.
29. Sigfússon G. Boyle GJ, Miller SA, Webber SA, Mi-
chaels MG, Kurland G, et al. Bronchiolitis Obliterans in
Children and Adolescent Following Heart / Lung Trans-
plantation. Pediatric Cardiology 1994; 15: 259 Abstract.
30. Baum D, Bernstein D, Starnes VA, Oyer P, Pitlick P,
Stinson E, et al. Pediatric heart transplantation at Stan-
ford: Results of a 15-year experience. Pediatrics 1991; 88:
203-14.
31. Armitage JA, FrickerFJ, delNidoP, StarzlTE, Hardes-
ty RL, Griffith BP. A decade (1982-1992) of pediatric
cardiac transplantation and the impact of FK 506 immu-
nosuppression. J Thorac Cardiovasc Surg 1993; 105:464-
73.
32. Bailey LL, Gundry SR, Razzouk AJ, Wang N, Sciolaro
CM, Chiavarelli M. Bless the babies: One hundred and
fifteen late survivors of heart transplantation during the
first year of life. J Thorac Cardiovasc Surg 1993; 105:
805-15.
33. Webber SA, Fricker FJ, Michaels M, Pickering RM, del
Nido PJ, Griffith BP, et al. Orthotopic heart trans-
plantation in children with congenital heart disease. Ann
Thorac Surg 1994; 58: 1664-9.
34. Hsu DT, Garafano RP, Douglas JF, Michler RE, Qoae-
gebeur JM, Gersony WM, et al. Exercise performance
after pediatric heart transplantation. Circulation 1993;
88: II 238-42.
35. Nixon PA, Fricker FJ, Noyes BE, Webber SA, Oren-
steins DM, Armitage JM. Exercise testing in pediatric
heart, heart-lung and lung transplant recipients. Chest
1995; 107: 1328-35.
36. Douglas JF, Hsu DT, Addonizio LJ. Noncompliance in
pediatric heart transplant patients. J Heart Lung Trans-
plant 1993; 12: 92.
37. Uzark KC, Sauer SN, Lawrence KS, Miller J, Addoni-
zio L, Crowley DC. The psychosocial impact of pediatric
heart transplantation. J Heart Lung Transplant 1992; 11:
1160-7.
38. Lawrence KS, Fricker FJ. Pediatric heart transplanta-
tion: Quality of life. J Heart Transplant 1987; 6: 329-
333.